Search
Now showing items 1-1 of 1
Pro-survival pathways in triple negative breast cancer: Focus on the roles of RIP2 and HSPB1
(2016-10-10)
Triple negative breast cancers (TNBC) lack estrogen and progesterone receptors, and HER-2 markers rendering them resistant to current targeted therapies. Most TNBCs show basal-like characteristics and the terms TNBC and ...